EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study

Robert J Rushakoff iD, Esther Rov-Ikpah, Gwendolyn Lee, Paras B Mehta, Craig San Luis, Craig Johnson, Suneil Koliwad iD, Cynthia Fenton iD, Michael A Kohn iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf376 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Robert J Rushakoff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, University of California, San Francisco, CA 94115, USA. Hauptthemen laut MEDLINE: Algorithms, Insulin, Hyperglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Achieving inpatient glycemic control in patients who are nil per os (NPO), on enteral tube feedings (TF), or total parental nutrition (TPN) remains extremely challenging.

Objective

To determine if, for inpatients with hyperglycemia who are NPO, on TF, or on TPN, an automated self-adjusting subcutaneous rapid-acting insulin algorithm (SQIA) we developed and programmed into the electronic medical record (EMR) leads to improvements in glucose control compared to conventional insulin treatment (CI).

Methods

Retrospective cohort study using EMR data from September 3, 2020, to September 2, 2023, of all adult inpatients, comparing point-of-care (POC) glucose measurements between patients on SQIA vs CI and either NPO, or on TF, or on TPN. The analysis looked at the proportion of q4 hour POC glucose levels in the following ranges: hypoglycemia (<70 mg/dL), in range (71-180 mg/dL), moderate hyperglycemia (181-250 mg/dL), and severe hyperglycemia (>250 mg/dL).

Results

There were 5031 intervals (associated with 4310 hospitalizations) in which the patient was NPO or on TF or TPN and on the SQIA (73.5%) or CI (26.5%). The proportion of glucose values in the hypoglycemic and severely hyperglycemic ranges were significantly lower in the SQIA group vs the CI group (hypoglycemia: 0.65% vs 1.10%; difference −0.45%; −0.62 to −0.28%; P < .001; hyperglycemia: 5.40% vs 6.65%; difference −1.25%; −2.03% to −0.46%; P = .002). With glucocorticoids, severe hyperglycemia rates were lower for patients on SQIA, particularly those receiving high-dose glucocorticoids (11.1% lower).

Conclusion

Patients had a lower proportion of both hypoglycemic and severely hyperglycemic measurements when their blood glucose levels were managed using the SQIA than when managed using conventional physician-driven insulin orders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsInsulinHyperglycemiaHypoglycemic AgentsGlycemic ControlHumansRetrospective StudiesFemaleMaleMiddle AgedBlood GlucoseInpatientsAgedHypoglycemiaAdultEnteral NutritionFollow-Up StudiesHospitalization

Stichwörter der Autor:innen

inpatient diabetes managementnil per osphysician efficiencyself-adjusting insulin administrationtotal parenteral nutritiontube feeding

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, University of California, San Francisco, CA 94115, USA.
  • Institute of Nursing Excellence, University of California, San Francisco, CA 94115, USA.
  • Department of Medicine, University of California, San Francisco, CA 94143, USA.
  • Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Clinical Systems, University of California, San Francisco, CA 94143, USA.
  • Department of Health Informatics, University of California, San Francisco, CA 94143, USA.

ORCID-Profile: Robert J Rushakoff, Suneil Koliwad, Cynthia Fenton, Michael A Kohn

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • UCSF-CTSI

Zitieren

APA

Rushakoff, R. J., Rov-Ikpah, E., Lee, G., Mehta, P. B., San Luis, C., Johnson, C., Koliwad, S., Fenton, C., & Kohn, M. A. (2026). Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf376

Vancouver

Rushakoff RJ, Rov-Ikpah E, Lee G, Mehta PB, San Luis C, Johnson C, et al. Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf376

BibTeX
@article{Rushakoff2026,
  author = {Rushakoff, Robert J and Rov-Ikpah, Esther and Lee, Gwendolyn and Mehta, Paras B and San Luis, Craig and Johnson, Craig and Koliwad, Suneil and Fenton, Cynthia and Kohn, Michael A},
  title = {Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf376}
}
Kostenlos starten →